Circulating Tumor Cells and Cancer Stem Cells Market Report

China Circulating Tumor Cells and Cancer Stem Cells Industry Market Research Report 2023-2029

  • POSTDATE：Oct 13, 2023
  • PAGES：187
  • REPORT CODE：GMM1851161
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Circulating Tumor Cells and Cancer Stem Cells industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Silicon Biosystems

    • QIAGEN Hannover

    • AVIVA Biosciences

    • Fluxion Biosciences

    • Advanced Cell Diagnostics

    • Rarecells

    • Epic Sciences

    • Janssen Diagnostics

    • ApoCell

    By Type:

    • Detection

    • Cell Enrichment

    • CTC Analysis

    By Application:

    • Medical Research Institute

    • Hospital

    • NSC

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Circulating Tumor Cells and Cancer Stem Cells Market Overview 2018-2029

    • 1.1 China Circulating Tumor Cells and Cancer Stem Cells Industry Development Overview

    • 1.2 China Circulating Tumor Cells and Cancer Stem Cells Industry Development History

    • 1.3 China Circulating Tumor Cells and Cancer Stem Cells Industry Market Size (2018-2029)

    • 1.4 China Circulating Tumor Cells and Cancer Stem Cells Market Analysis by Type from Production Side

      • 1.4.1 China Circulating Tumor Cells and Cancer Stem Cells Production Volume, Production Value and Growth Rate of Detection (2018-2029)

      • 1.4.2 China Circulating Tumor Cells and Cancer Stem Cells Production Volume, Production Value and Growth Rate of Cell Enrichment (2018-2029)

      • 1.4.3 China Circulating Tumor Cells and Cancer Stem Cells Production Volume, Production Value and Growth Rate of CTC Analysis (2018-2029)

    • 1.5 China Circulating Tumor Cells and Cancer Stem Cells Market Analysis by Application from Consumption End

      • 1.5.1 China Circulating Tumor Cells and Cancer Stem Cells Sales Volume, Sales Value and Growth Rate of Medical Research Institute (2018-2029)

      • 1.5.2 China Circulating Tumor Cells and Cancer Stem Cells Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Circulating Tumor Cells and Cancer Stem Cells Sales Volume, Sales Value and Growth Rate of NSC (2018-2029)

    • 1.6 China Circulating Tumor Cells and Cancer Stem Cells Market Analysis by Region

      • 1.6.1 North China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

    Chapter 2 China Circulating Tumor Cells and Cancer Stem Cells Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Circulating Tumor Cells and Cancer Stem Cells Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Circulating Tumor Cells and Cancer Stem Cells Market Status and Competition Analysis in 2023

      • 2.2.3 China Circulating Tumor Cells and Cancer Stem Cells Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Circulating Tumor Cells and Cancer Stem Cells Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Circulating Tumor Cells and Cancer Stem Cells Industry Development

    Chapter 3 Circulating Tumor Cells and Cancer Stem CellsIndustry Chain Analysis

    • 3.1 Circulating Tumor Cells and Cancer Stem Cells Industry Chain

    • 3.2 Circulating Tumor Cells and Cancer Stem Cells Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Circulating Tumor Cells and Cancer Stem Cells Market

    • 3.3 Circulating Tumor Cells and Cancer Stem Cells Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Circulating Tumor Cells and Cancer Stem Cells Market

    Chapter 4 China Circulating Tumor Cells and Cancer Stem Cells Market, by Type

    • 4.1 China Circulating Tumor Cells and Cancer Stem Cells Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Circulating Tumor Cells and Cancer Stem Cells Total Production Volume and Growth Rate from Production Side

    • 4.5 China Circulating Tumor Cells and Cancer Stem Cells Production Volume and Growth Rate, by Type

      • 4.5.1 China Circulating Tumor Cells and Cancer Stem Cells Production Volume and Growth Rate of Detection

      • 4.5.2 China Circulating Tumor Cells and Cancer Stem Cells Production Volume and Growth Rate of Cell Enrichment

      • 4.5.3 China Circulating Tumor Cells and Cancer Stem Cells Production Volume and Growth Rate of CTC Analysis

    Chapter 5 China Circulating Tumor Cells and Cancer Stem Cells Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Circulating Tumor Cells and Cancer Stem Cells Total Market Size and Growth Rate from Consumption End

    • 5.5 China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate, by Application

      • 5.5.1 China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate of Medical Research Institute

      • 5.5.2 China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate of Hospital

      • 5.5.3 China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate of NSC

    Chapter 6 China Circulating Tumor Cells and Cancer Stem Cells Market, by Region

    • 6.1 China Circulating Tumor Cells and Cancer Stem Cells Production Volume and Production Value, by Region

    • 6.2 China Circulating Tumor Cells and Cancer Stem Cells Sales Volume and Sales Value, by Region

    Chapter 7 North China Circulating Tumor Cells and Cancer Stem Cells Market Analysis

    • 7.1 North China Circulating Tumor Cells and Cancer Stem Cells Market, by Type

    • 7.2 North China Circulating Tumor Cells and Cancer Stem Cells Market, by Application

    Chapter 8 Central China Circulating Tumor Cells and Cancer Stem Cells Market Analysis

    • 8.1 Central China Circulating Tumor Cells and Cancer Stem Cells Market, by Type

    • 8.2 Central China Circulating Tumor Cells and Cancer Stem Cells Market, by Application

    Chapter 9 South China Circulating Tumor Cells and Cancer Stem Cells Market Analysis

    • 9.1 South China Circulating Tumor Cells and Cancer Stem Cells Market, by Type

    • 9.2 South China Circulating Tumor Cells and Cancer Stem Cells Market, by Application

    Chapter 10 East China Circulating Tumor Cells and Cancer Stem Cells Market Analysis

    • 10.1 East China Circulating Tumor Cells and Cancer Stem Cells Market, by Type

    • 10.2 East China Circulating Tumor Cells and Cancer Stem Cells Market, by Application

    Chapter 11 Northeast China Circulating Tumor Cells and Cancer Stem Cells Market Analysis

    • 11.1 Northeast China Circulating Tumor Cells and Cancer Stem Cells Market, by Type

    • 11.2 Northeast China Circulating Tumor Cells and Cancer Stem Cells Market, by Application

    Chapter 12 Southwest China Circulating Tumor Cells and Cancer Stem Cells Market Analysis

    • 12.1 Southwest China Circulating Tumor Cells and Cancer Stem Cells Market, by Type

    • 12.2 Southwest China Circulating Tumor Cells and Cancer Stem Cells Market, by Application

    Chapter 13 Northwest China Circulating Tumor Cells and Cancer Stem Cells Market Analysis

    • 13.1 Northwest China Circulating Tumor Cells and Cancer Stem Cells Market, by Type

    • 13.2 Northwest China Circulating Tumor Cells and Cancer Stem Cells Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Silicon Biosystems

        • 14.1.1 Silicon Biosystems Company Profile

        • 14.1.2 Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 QIAGEN Hannover

        • 14.2.1 QIAGEN Hannover Company Profile

        • 14.2.2 QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 AVIVA Biosciences

        • 14.3.1 AVIVA Biosciences Company Profile

        • 14.3.2 AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Fluxion Biosciences

        • 14.4.1 Fluxion Biosciences Company Profile

        • 14.4.2 Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Advanced Cell Diagnostics

        • 14.5.1 Advanced Cell Diagnostics Company Profile

        • 14.5.2 Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Rarecells

        • 14.6.1 Rarecells Company Profile

        • 14.6.2 Rarecells Circulating Tumor Cells and Cancer Stem Cells Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Epic Sciences

        • 14.7.1 Epic Sciences Company Profile

        • 14.7.2 Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Janssen Diagnostics

        • 14.8.1 Janssen Diagnostics Company Profile

        • 14.8.2 Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 ApoCell

        • 14.9.1 ApoCell Company Profile

        • 14.9.2 ApoCell Circulating Tumor Cells and Cancer Stem Cells Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Circulating Tumor Cells and Cancer Stem Cells Industry Research Conclusions

    • 15.2 Circulating Tumor Cells and Cancer Stem Cells Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Industry Market Size (2018-2029)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Production Volume, Production Value and Growth Rate of Detection (2018-2029)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Production Volume, Production Value and Growth Rate of Cell Enrichment (2018-2029)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Production Volume, Production Value and Growth Rate of CTC Analysis (2018-2029)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Sales Volume, Sales Value and Growth Rate of Medical Research Institute (2018-2029)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Sales Volume, Sales Value and Growth Rate of NSC (2018-2029)

    • Figure North China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Central China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure South China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure East China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Circulating Tumor Cells and Cancer Stem Cells Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Market Share by Type in 2018

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Market Share by Type in 2023

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Production Volume and Growth Rate of Detection (2018-2023)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Production Volume and Growth Rate of Cell Enrichment (2018-2023)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Production Volume and Growth Rate of CTC Analysis (2018-2023)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Market Share by Application in 2018

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Market Share by Application in 2023

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Total Market Size and Growth Rate from Consumption End

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate of Medical Research Institute (2018-2023)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Market Size and Growth Rate of NSC (2018-2023)

    • Table China Circulating Tumor Cells and Cancer Stem Cells Production Volume by Region (2018-2023)

    • Table China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Region (2018-2023)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Region (2018-2023)

    • Table China Circulating Tumor Cells and Cancer Stem Cells Production Value by Region (2018-2023)

    • Table China Circulating Tumor Cells and Cancer Stem Cells Production Value Share by Region (2018-2023)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Production Value Share by Region (2018-2023)

    • Table China Circulating Tumor Cells and Cancer Stem Cells Sales Volume by Region (2018-2023)

    • Table China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Region (2018-2023)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Region (2018-2023)

    • Table China Circulating Tumor Cells and Cancer Stem Cells Sales Value by Region (2018-2023)

    • Table China Circulating Tumor Cells and Cancer Stem Cells Sales Value Share by Region (2018-2023)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Sales Value Share by Region (2018-2023)

    • Table North China Circulating Tumor Cells and Cancer Stem Cells Production Volume by Type (2018-2023)

    • Table North China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Figure North China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Table North China Circulating Tumor Cells and Cancer Stem Cells Sales Volume by Application (2018-2023)

    • Table North China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure North China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Central China Circulating Tumor Cells and Cancer Stem Cells Production Volume by Type (2018-2023)

    • Table Central China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Central China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Table Central China Circulating Tumor Cells and Cancer Stem Cells Sales Volume by Application (2018-2023)

    • Table Central China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Central China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Table South China Circulating Tumor Cells and Cancer Stem Cells Production Volume by Type (2018-2023)

    • Table South China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Figure South China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Table South China Circulating Tumor Cells and Cancer Stem Cells Sales Volume by Application (2018-2023)

    • Table South China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure South China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Table East China Circulating Tumor Cells and Cancer Stem Cells Production Volume by Type (2018-2023)

    • Table East China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Figure East China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Table East China Circulating Tumor Cells and Cancer Stem Cells Sales Volume by Application (2018-2023)

    • Table East China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure East China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Northeast China Circulating Tumor Cells and Cancer Stem Cells Production Volume by Type (2018-2023)

    • Table Northeast China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Northeast China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Table Northeast China Circulating Tumor Cells and Cancer Stem Cells Sales Volume by Application (2018-2023)

    • Table Northeast China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Southwest China Circulating Tumor Cells and Cancer Stem Cells Production Volume by Type (2018-2023)

    • Table Southwest China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Southwest China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Table Southwest China Circulating Tumor Cells and Cancer Stem Cells Sales Volume by Application (2018-2023)

    • Table Southwest China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Northwest China Circulating Tumor Cells and Cancer Stem Cells Production Volume by Type (2018-2023)

    • Table Northwest China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Northwest China Circulating Tumor Cells and Cancer Stem Cells Production Volume Share by Type (2018-2023)

    • Table Northwest China Circulating Tumor Cells and Cancer Stem Cells Sales Volume by Application (2018-2023)

    • Table Northwest China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Circulating Tumor Cells and Cancer Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Silicon Biosystems Company Profile

    • Table Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Revenue, Price and Gross (2018-2023)

    • Table QIAGEN Hannover Company Profile

    • Table QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Revenue, Price and Gross (2018-2023)

    • Table AVIVA Biosciences Company Profile

    • Table AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Fluxion Biosciences Company Profile

    • Table Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Advanced Cell Diagnostics Company Profile

    • Table Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Rarecells Company Profile

    • Table Rarecells Circulating Tumor Cells and Cancer Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Epic Sciences Company Profile

    • Table Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Janssen Diagnostics Company Profile

    • Table Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Revenue, Price and Gross (2018-2023)

    • Table ApoCell Company Profile

    • Table ApoCell Circulating Tumor Cells and Cancer Stem Cells Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US